CUSIP: Q73622104
Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
1,700,403
-
Share change
-
-1,124,574
-
Total reported value
-
$1,172,000
-
Price per share
-
$0.69
-
Number of holders
-
16
-
Value change
-
-$783,320
-
Number of buys
-
4
-
Number of sells
-
12
Quarterly Holders Quick Answers
What is CUSIP Q73622104?
CUSIP Q73622104 identifies PARNF - PARNELL PHARMACEUT HLDGS LTD - SHS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2017
-
Previous quarter:
Q3 2016
Recent filing periods for CUSIP Q73622104:
Institutional Holders of PARNELL PHARMACEUT HLDGS LTD - SHS (PARNF) as of Q4 2016
As of 31 Dec 2016,
PARNELL PHARMACEUT HLDGS LTD - SHS (PARNF) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,700,403 shares.
The largest 10 holders included
BlackRock Advisors LLC, Endurant Capital Management LP, BlackRock Group LTD, SABBY MANAGEMENT, LLC, Alyeska Investment Group, L.P., BlackRock Inc., BlackRock Investment Management, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, KCG HOLDINGS, INC., and FMR LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.